Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study

Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study

Background: non-small cell lung cancer (NSCLC) outcomes remain suboptimal for early-stage disease despite emerging advances in systemic therapy for the peri-operative period. Next-generation sequencing (NGS) identifies driver mutations for which targeted therapies have been developed that improve su...

Full description

Bibliographic Details
Main Authors: Roy Avraham Hilzenrat, Stephen Yip, Barbara Melosky, Cheryl Ho, Janessa Laskin, Sophie Sun, James J. Choi, Anna L. McGuire
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Current Oncology
Subjects:
non-small cell lung cancer
thoracic malignancy
cancer care
driver mutations
British Columbia
Online Access:https://www.mdpi.com/1718-7729/30/1/12

Internet

https://www.mdpi.com/1718-7729/30/1/12

Similar Items